Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Significant Growth in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 17,500 shares, a growth of 21.5% from the November 15th total of 14,400 shares. Based on an average trading volume of 20,900 shares, the days-to-cover ratio is currently 0.8 days.

Reviva Pharmaceuticals Stock Down 11.3 %

Reviva Pharmaceuticals stock traded down $0.04 during trading on Friday, reaching $0.31. The stock had a trading volume of 18,848 shares, compared to its average volume of 18,631. Reviva Pharmaceuticals has a 52-week low of $0.07 and a 52-week high of $1.62. The business has a 50 day moving average price of $0.17 and a 200 day moving average price of $0.18.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.